A Study of ABT-751 in Patients With Renal Cell Cancer
Public ClinicalTrials.gov record NCT00073112. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Study of ABT-751 in Subjects With Refractory Colorectal Carcinoma
Study identification
- NCT ID
- NCT00073112
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Abbott
- Industry
- Enrollment
- 60 participants
Conditions and interventions
Conditions
Interventions
- ABT-751 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2003
- Primary completion
- Not listed
- Completion
- Aug 31, 2006
- Last update posted
- Nov 28, 2007
2003 – 2006
United States locations
- U.S. sites
- 19
- U.S. states
- 13
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Cancer Research Center | Tucson | Arizona | 85712 | — |
| UCLA School of Medicine | Los Angeles | California | 90024 | — |
| Clinical Trials + Research Associates | Montebello | California | 90640 | — |
| US Oncology Inc Rocky Mountain Cancer Centers | Denver | Colorado | 80218 | — |
| Oncology Hematology Group of South Florida | Miami | Florida | — | — |
| US Oncology Inc Florida Cancer Institute | New Port Richey | Florida | 34652 | — |
| US Oncology Inc Ocala Oncology Center | Ocala | Florida | 34474 | — |
| US Oncology Inc Cancer Centers of Florida, P.A. | Orlando | Florida | 32806 | — |
| University of Chicago Medical Center | Chicago | Illinois | 60637-1471 | — |
| Sidney Kimmel Comprehensive Cancer Center | Baltimore | Maryland | 21231 | — |
| US Oncology Inc Raleigh Hematology Oncology Clinic | Cary | North Carolina | 27511 | — |
| US Oncology Inc Dayton Oncology & Hematology P.A. | Kettering | Ohio | 45409 | — |
| US Oncology Inc Cancer Care Accociates-Mercy Campus | Oklahoma City | Oklahoma | 73120 | — |
| US Oncology Inc Cancer Centers of the Carolinas | Greenville | South Carolina | 29615 | — |
| West Cancer Clinic | Memphis | Tennessee | 38120 | — |
| Vanderbilt Ingram Cancer Center | Nashville | Tennessee | 37232-6307 | — |
| US Oncology Inc Tyler Cancer Center | Tyler | Texas | 75702 | — |
| US Oncology Inc Cancer Care Northwest-North | Spokane | Washington | 99218 | — |
| US Oncology Inc Northwest Cancer Specialists | Vancouver | Washington | 98684 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00073112, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 28, 2007 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00073112 live on ClinicalTrials.gov.